Results 221 to 230 of about 4,850,533 (302)

Comprehensive survival analysis of breast cancer patients: a bayesian network approach. [PDF]

BMC Med Inform Decis Mak
Toffaha K, Emre Simsekler MC, Shehhi AA, Sleptchenko A, AlAwadhi A.   +4 more
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Lu CH, Chang CW, Chen SC, Kao WY, Ting WY, Lu CH, Chuang KI, Ni CF, Hsieh YY, Wu MS, Su CW, Chang CC, Wu CH.   +12 more
europepmc   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Survival Analysis and Treatment Strategies for Locally Advanced Lung Squamous Cell Carcinoma in Elderly Patients. [PDF]

World J Oncol
Jia ZF, Zhao XZ, Huo JC, Wang YX, Yang J.   +4 more
europepmc   +1 more source

Prognostic Factors for Survival in Patients with Colorectal Cancer in Iran between 2004-2015: Competing Risks Regression Analysis with Generalized Weibull Model

, 2017
Soraya Moamer, Ahmad Reza Baghestani, Mohamad Amin Pourhoseingholi, Ali Akbar Khaden Maboudi, Seyed Hossein Seyed Agha, Mohammad Reza Zali   +5 more
openalex   +1 more source

A 22 years survival and prognostic factors analysis in a homogeneous series of 64 patients with advanced cancer of the tongue and the floor of the mouth

, 2015
J.L. López-Cedrún, J Andrés de Llano
openalex   +2 more sources

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Predictors of marriage to first birth interval in Amhara regional state, Ethiopia: survival analysis. [PDF]

BMC Womens Health
Negash BT, Tsegaye TG, Azeze GA, Zewude YA.   +3 more
europepmc   +1 more source

An Introduction to Survival Analysis using Stata [PDF]

Thomas Lumley
core   +1 more source